AtriCure (ATRC) Cash from Investing Activities (2010 - 2026)

AtriCure (ATRC) has 17 years of Cash from Investing Activities data on file, last reported at -$3.9 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 129.15% year-over-year to -$3.9 million in Q1 2026; TTM through Mar 2026 was -$16.7 million, a 188.43% decrease from a year earlier, with the FY2025 full-year figure at -$14.6 million, down 148.12% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$3.9 million, down from -$2.6 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for ATRC reached as high as $30.9 million in Q2 2024 and fell as low as -$16.1 million in Q2 2023.
• Historically, Cash from Investing Activities has averaged $4.6 million across 5 years, with a median of -$1.7 million in 2025.
• Across the five-year window, Cash from Investing Activities jumped 550.14% in 2022 and slumped 427.39% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at $7.0 million in 2022, then tumbled by 139.79% to -$2.8 million in 2023, then slumped by 427.39% to -$14.7 million in 2024, then soared by 82.29% to -$2.6 million in 2025, then sank by 48.04% to -$3.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$3.9 million in Q1 2026, -$2.6 million in Q4 2025, and -$2.6 million in Q3 2025.